Miriam Massaad, a biomedical engineering student at Boston University, shares her experiences as a first-time attendee at the 2018 BIO International Convention and Conference in Boston.
Robert Coughlin, president and CEO of MassBio, discusses his organization’s approach to diversity and inclusion.
Dave Thomas, managing director for industry research and analysis at the Biotechnology Innovation Organization (BIO), discusses chronic disease research and other industry trends.
Shaness Grenald, Ph.D., a postdoctoral fellow in the department of anesthesiology and critical care medicine at Johns Hopkins University, discusses the Scientist Mentoring and Diversity Program (SMDP) at the 2018 BIO Buzz Center in Boston.
I imagine George Yancopoulos, profiled on this month’s cover, to have gained some of his life’s wisdom in a similar fashion to most people — by trying new things.
An exclusive interview with George Yancopoulos who talks about why his partnership with Len Schleifer has lasted so long and how “wild ideas” have served as the underlying theme to Regeneron.
Tips to help you get ready for the 2018 BIO International Convention in Boston, June 4 - 7.
Rob Wright discusses the open office concept, and if it is an idea that should be killed.
Rob Wright discusses the unusual genesis of the Regeneron Genetics Center (RGC).